On October 31, 2012, Ameridose announced a voluntary recall of all products that are not expired. Due to unsafe practices in manufacturing and sterility, Ameridose has agreed to comply with the U.S. Food and Drug Administration and the Massachusetts Board of Registration in Pharmacy to issue the recall and prevent any possible hazards which could occur from these products. The FDA will require Ameridose to improve its sterility procedures in order to ensure safety of the products.
No serious side effects have been reported to the FDA since the release of the products. Also, there have been no contaminated products found. However if taken, contaminated medications may pose a significant threat and even death to patients.
If you believe you have an unexpired Ameridose product:
As a further precaution, Ameridose will be shut down until 2013 to reach safety standards established by the FDA and the Centers for Disease Control and Prevention. To protect patients, all production will be stopped. According to the FDA, this may result in a shortage of certain products. If you think you have a product that may be involved in the shortage, email the U.S. Food and Drug Administration Drug Shortage Staff at drugshortages@fda.hhs.gov.
Learn more information about the recall and other medical news at bad-drug.net.
0."/>